These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19864105)

  • 1. Characterization of a novel impurity in bulk drug eprosartan by ESI/MS(n) and NMR.
    Sun C; Wu J; Wang D; Pan Y
    J Pharm Biomed Anal; 2010 Feb; 51(3):778-83. PubMed ID: 19864105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and relative response factor determination of process related impurity in Naproxen by nuclear magnetic resonance spectroscopy.
    Iqbal MY; Rao KM; Sridhar G; Raju PP; Deshpande GR; Babu JM
    J Pharm Biomed Anal; 2011 Nov; 56(3):484-90. PubMed ID: 21782369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of a potential process related impurity of phenazopyridine HCl by preparative HPLC followed by MS-MS and 2D-NMR spectroscopy.
    Rao RN; Maurya PK; Raju AN
    J Pharm Biomed Anal; 2009 Jul; 49(5):1287-91. PubMed ID: 19376664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of impurities in semi-synthetic vinorelbine bitartrate by HPLC-MS with mass spectrometric shift technique.
    Cao X; Tai Y; Sun C; Wang K; Pan Y
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):39-45. PubMed ID: 16085133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the trace-level impurities in the bulk drug citalopram by high-performance liquid chromatography/tandem multistage mass spectrometry.
    Sun C; Xu H; Pan Y; Shen Z; Wang D
    Rapid Commun Mass Spectrom; 2007; 21(17):2889-94. PubMed ID: 17663502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
    Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectral and polarographic determination of eprosartan. Kinetic studies of the oxidation of eprosartan using a platinum electrode.
    El-Yazbi FA; Hammud HH; Sonji NM; Sonji GM
    Pharmazie; 2008 Jun; 63(6):420-7. PubMed ID: 18604984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-covalent dimer formed in electrospray ionisation mass spectrometry behaving as a precursor for fragmentations.
    Pan H
    Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3555-60. PubMed ID: 18853406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an unknown trace-level impurity in bulk drug of Seroquel by high-performance liquid chromatography combined with mass spectrometry.
    Xu H; Wang D; Sun C; Pan Y; Zhou M
    J Pharm Biomed Anal; 2007 Jun; 44(2):414-20. PubMed ID: 17420108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrogen purity influences the occurrence of As+ ions in high-performance liquid chromatography/electrospray ionization mass spectrometric analysis of four common arsenosugars.
    Kuehnelt D; Goessler W; Francesconi KA
    Rapid Commun Mass Spectrom; 2003; 17(7):654-9. PubMed ID: 12661017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of novel hydrolysis products of carbapenems by electrospray ionization mass spectrometry.
    Sun C; Wu J; Pan Y
    Rapid Commun Mass Spectrom; 2009 Oct; 23(19):3205-12. PubMed ID: 19718775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of eprosartan in human plasma and urine by LC/MS/MS.
    Li XN; Xu HR; Chen WL; Liu GY; Chu NN; Yu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):47-53. PubMed ID: 17409033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of ceramides in cosmetics by reversed-phase liquid chromatography/electrospray ionization mass spectrometry with collision-induced dissociation.
    Lee MH; Lee GH; Yoo JS
    Rapid Commun Mass Spectrom; 2003; 17(1):64-75. PubMed ID: 12478556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and structural identification of an impurity in fluconazole bulk drug substance.
    Dongre VG; Ghugare PD; Karmuse PP; Soudagar SR; Panda N; Kumar A
    J Pharm Biomed Anal; 2007 Nov; 45(3):422-9. PubMed ID: 17706390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation and characterization of synthetic impurities of triclabendazole by reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry.
    Zhou H; Tai Y; Sun C; Pan Y
    J Pharm Biomed Anal; 2005 Feb; 37(1):97-107. PubMed ID: 15664748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of constituents with molecular diversity in fractions from Lysidice brevicalyx by liquid chromatography/diode-array detection/electrospray ionization tandem mass spectrometry and liquid chromatography/nuclear magnetic resonance.
    Qu J; Hu YC; Li JB; Wang YH; Zhang JL; Abliz Z; Yu SS; Liu YB
    Rapid Commun Mass Spectrom; 2008; 22(6):755-65. PubMed ID: 18288769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cardiac glycosides in fractions from Periploca forrestii by high-performance liquid chromatography/diode-array detection/electrospray ionization multi-stage tandem mass spectrometry and liquid chromatography/nuclear magnetic resonance.
    Li Y; Wu X; Li J; Wang Y; Yu S; Lv H; Qu J; Abliz Z; Liu J; Liu Y; Du D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):381-90. PubMed ID: 20042379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas-phase fragmentation study of novel synthetic 1,5-benzodiazepine derivatives using electrospray ionization tandem mass spectrometry.
    Rida M; El Meslouhi H; Es-Safi NE; Essassi el M; Banoub J
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2253-68. PubMed ID: 18561279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a principal oxidation impurity in clopidogrel drug substance and drug product.
    Mohan A; Hariharan M; Vikraman E; Subbaiah G; Venkataraman BR; Saravanan D
    J Pharm Biomed Anal; 2008 May; 47(1):183-9. PubMed ID: 18313249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
    Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
    J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.